Type 2 Diabetes Clinical Trials Recruiting in the US
258 studies for Type 2 Diabetes are recruiting at 1,472 US sites, according to ClinicalTrials.gov data processed .
Type 2 diabetes is a long-term condition in which the body does not use insulin well, leading to high blood sugar levels.
Recruiting now
Top Type 2 Diabetes studies by number of US sites
Showing 30 studies, most US recruiting sites first.
- EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
NCT07064473
- Phase 3
- Ages 18 years and older
- Sex: All
- Recruiting sites
- 201 US recruiting sites
- A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
NCT06112418
- Interventional
- Ages 55 years and older
- Sex: All
- Accepts healthy volunteers
- Recruiting sites
- 122 US recruiting sites
- Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
NCT07296484
- Phase 2
- Ages 18 years and older
- Sex: All
- Recruiting sites
- 61 US recruiting sites
- A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
NCT07282600
- Phase 3
- Ages 18 years and older
- Sex: All
- Recruiting sites
- 60 US recruiting sites
- A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
NCT07754461
- Phase 3
- Ages 18 years and older
- Sex: All
- Recruiting sites
- 57 US recruiting sites
- Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
NCT07271186
- Phase 2
- Ages 18 to 80 years
- Sex: All
- Recruiting sites
- 56 US recruiting sites
- AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
NCT07797335
- Phase 3
- Ages 45 years and older
- Sex: All
- Recruiting sites
- 56 US recruiting sites
- A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
NCT07351058
- Phase 3
- Ages 18 years and older
- Sex: All
- Recruiting sites
- 45 US recruiting sites
- A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
NCT07654374
- Phase 3
- Ages 18 to 79 years
- Sex: All
- Accepts healthy volunteers
- Recruiting sites
- 43 US recruiting sites
- A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
NCT06739122
- Phase 3
- Ages 10 to 17 years
- Sex: All
- Recruiting sites
- 40 US recruiting sites
- Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema
NCT07817251
- Phase 3
- Ages 18 years and older
- Sex: All
- Recruiting sites
- 37 US recruiting sites
- A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
NCT07340320
- Phase 2
- Ages 18 to 75 years
- Sex: All
- Recruiting sites
- 33 US recruiting sites
- Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
NCT07684144
- Phase 3
- Ages 18 to 99 years
- Sex: All
- Recruiting sites
- 31 US recruiting sites
- A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
NCT07595549
- Phase 3
- Ages 18 years and older
- Sex: All
- Recruiting sites
- 30 US recruiting sites
- A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
NCT07783802
- Phase 2
- Ages 18 years and older
- Sex: All
- Recruiting sites
- 29 US recruiting sites
- The RESET System Pivotal Clinical Trial (Protocol Revision K)
NCT04101669
- Interventional
- Ages 22 to 65 years
- Sex: All
- Recruiting sites
- 26 US recruiting sites
- A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
NCT06897475
- Phase 2
- Ages 18 to 75 years
- Sex: All
- Recruiting sites
- 25 US recruiting sites
- Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
NCT07521475
- Interventional
- Ages 18 to 75 years
- Sex: All
- Recruiting sites
- 25 US recruiting sites
- HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes
NCT07546929
- Phase 2
- Ages 18 years and older
- Sex: All
- Recruiting sites
- 25 US recruiting sites
- A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
NCT07668388
- Phase 2
- Ages 18 to 75 years
- Sex: All
- Recruiting sites
- 21 US recruiting sites
- DISCOVERY of Risk Factors for Type 2 Diabetes in Youth
NCT06525259
- Observational
- Ages 8 to 15 years
- Sex: All
- Recruiting sites
- 20 US recruiting sites
- A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
NCT07415954
- Phase 2
- Ages 18 to 75 years
- Sex: All
- Recruiting sites
- 20 US recruiting sites
- Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy
NCT07502508
- Phase 2
- Ages 18 to 70 years
- Sex: All
- Recruiting sites
- 17 US recruiting sites
- A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
NCT07282613
- Phase 3
- Ages 10 to 18 years
- Sex: All
- Recruiting sites
- 14 US recruiting sites
- Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus
NCT07527650
- Phase 2
- Ages 18 to 75 years
- Sex: All
- Recruiting sites
- 14 US recruiting sites
- Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System
NCT07579702
- Interventional
- Ages 14 to 75 years
- Sex: All
- Recruiting sites
- 11 US recruiting sites
- Rising Tide - Amniotic Tissue(s) Treatments for Chronic Diabetic Foot Ulcers
NCT06681428
- Interventional
- Ages 18 years and older
- Sex: All
- Recruiting sites
- 9 US recruiting sites
- Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus
NCT07282743
- Phase 2
- Ages 18 years and older
- Sex: All
- Recruiting sites
- 9 US recruiting sites
- A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies
NCT07606066
- Observational
- Ages 18 years and older
- Sex: All
- Recruiting sites
- 8 US recruiting sites
- CGM for Management of Type 2 Diabetes in Pregnancy
NCT06628453
- Interventional
- Ages 18 to 50 years
- Sex: Female
- Recruiting sites
- 7 US recruiting sites
By city
Type 2 Diabetes clinical trials by city
FAQ
Common questions
What is a clinical trial?
A clinical trial is a research study in people that tests a medical, surgical or behavioral intervention, such as an investigational drug or device. Observational studies are also listed: they collect information without assigning a treatment. Read how clinical trials work.
Is there compensation for joining a Type 2 Diabetes clinical trial?
Compensation for time and travel may be available, but it varies by study and some studies offer none. The amount and schedule are reviewed by an ethics board and described in the consent form. See compensation in clinical trials.
How do I check if I'm eligible?
Each study lists age, sex and other inclusion and exclusion criteria on its ClinicalTrials.gov record. Only the study team can confirm eligibility, usually through a screening call or visit. Talk with your own doctor before joining any study.
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.